144 related articles for article (PubMed ID: 37457220)
81. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
[TBL] [Abstract][Full Text] [Related]
82. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
83. The effect of treating institution on outcomes in head and neck cancer.
Lassig AA; Joseph AM; Lindgren BR; Fernandes P; Cooper S; Schotzko C; Khariwala S; Reynolds M; Yueh B
Otolaryngol Head Neck Surg; 2012 Dec; 147(6):1083-92. PubMed ID: 22875780
[TBL] [Abstract][Full Text] [Related]
84. An evaluation of outcomes in patients with traumatic brain injury at a referral hospital in Tanzania: evidence from a survival analysis.
Elahi C; Rocha TAH; da Silva NC; Sakita FM; Ndebea AS; Fuller A; Haglund MM; Mmbaga BT; Nickenig Vissoci JR; Staton CA
Neurosurg Focus; 2019 Nov; 47(5):E6. PubMed ID: 31675716
[TBL] [Abstract][Full Text] [Related]
85. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
86. Prognosis of patients with multifocal glioblastoma: a case-control study.
Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
[TBL] [Abstract][Full Text] [Related]
87. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
88. Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.
Wright CH; Wright J; Cioffi G; Hdeib A; Kasliwal MK; Kruchko C; Barnholtz-Sloan JS; Sloan AE
J Neurosurg Spine; 2019 Nov; 32(2):311-320. PubMed ID: 31675723
[TBL] [Abstract][Full Text] [Related]
89. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.
Yang W; Xu T; Garzon-Muvdi T; Jiang C; Huang J; Chaichana KL
World Neurosurg; 2018 Mar; 111():e323-e334. PubMed ID: 29258929
[TBL] [Abstract][Full Text] [Related]
90. Primary glioblastoma multiforme in younger patients: a single-institution experience.
Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
[TBL] [Abstract][Full Text] [Related]
91. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
92. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
93. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
Thumma SR; Fairbanks RK; Lamoreaux WT; Mackay AR; Demakas JJ; Cooke BS; Elaimy AL; Hanson PW; Lee CM
World J Surg Oncol; 2012 May; 10():75. PubMed ID: 22553975
[TBL] [Abstract][Full Text] [Related]
94. Socioeconomic impact on device-associated infections in pediatric intensive care units of 16 limited-resource countries: international Nosocomial Infection Control Consortium findings.
Rosenthal VD; Jarvis WR; Jamulitrat S; Silva CP; Ramachandran B; Dueñas L; Gurskis V; Ersoz G; Novales MG; Khader IA; Ammar K; Guzmán NB; Navoa-Ng JA; Seliem ZS; Espinoza TA; Meng CY; Jayatilleke K;
Pediatr Crit Care Med; 2012 Jul; 13(4):399-406. PubMed ID: 22596065
[TBL] [Abstract][Full Text] [Related]
95. Lower middle-income countries: A risk factor for lower survival in glioblastoma? Evidence for health care providers.
Oberndorfer S
Neurooncol Pract; 2023 Aug; 10(4):320-321. PubMed ID: 37457229
[No Abstract] [Full Text] [Related]
96. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.
Pöhlmann J; Weller M; Marcellusi A; Grabe-Heyne K; Krott-Coi L; Rabar S; Pollock RF
Front Oncol; 2024; 14():1368606. PubMed ID: 38571509
[TBL] [Abstract][Full Text] [Related]
97. Glioblastoma management in a lower middle-income country: Nationwide study of compliance with standard care protocols and survival outcomes in Ukraine.
Rozumenko A; Kliuchka V; Rozumenko V; Daschakovskiy A; Fedorenko Z
Neurooncol Pract; 2023 Aug; 10(4):352-359. PubMed ID: 37457220
[TBL] [Abstract][Full Text] [Related]
98. The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care.
Salem A; Hashem SA; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Sughayer M; Mohamad I; Elyan M; Addas A; Al-Hussaini M; Almousa A
Hematol Oncol Stem Cell Ther; 2011; 4(3):116-20. PubMed ID: 21982884
[TBL] [Abstract][Full Text] [Related]
99. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
100. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
